← feed

Is NCT03509285 results overdue?

Yes — results are overdue. Primary completion was 2017-11-18; the FDAAA-801 reporting deadline (2018-11-18) passed 2772 days ago and no results are posted on ClinicalTrials.gov.

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

NCT IDNCT03509285 ↗
SponsorSK Life Science, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2017-11-18 (ACTUAL)
Reporting deadline2018-11-18 (completion + 365d)
Days overdue2772
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 6121395b36705e02… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03509285. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →